David Howe, PhD

Praedicare Inc.

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1697 - Dose-response Studies of the Novel Bacterial Leucyl-tRNA Synthetase Inhibitor, Epetraborole, in the Intracellular Hollow Fiber System Model of Mycobacterium avium complex Lung Disease
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 1698 - Pharmacokinetics/pharmacodynamics of Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor, and High Intracellular Penetration in the Intracellular Hollow Fiber System Model of Mycobacterium avium Complex Lung Disease
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET